1bl4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1bl4.gif|left|200px]]<br /><applet load="1bl4" size="350" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1bl4.gif|left|200px]]
-
caption="1bl4, resolution 1.9&Aring;" />
+
 
-
'''FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND'''<br />
+
{{Structure
 +
|PDB= 1bl4 |SIZE=350|CAPTION= <scene name='initialview01'>1bl4</scene>, resolution 1.9&Aring;
 +
|SITE=
 +
|LIGAND= <scene name='pdbligand=AP1:{3-[3-(3,4-DIMETHOXY-PHENYL)-1-(1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)-PROPYL]-PHENOXY}-ACETIC ACID'>AP1</scene>
 +
|ACTIVITY= [http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8]
 +
|GENE=
 +
}}
 +
 
 +
'''FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND'''
 +
 
==Overview==
==Overview==
Line 7: Line 16:
==About this Structure==
==About this Structure==
-
1BL4 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=AP1:'>AP1</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1BL4 OCA].
+
1BL4 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1BL4 OCA].
==Reference==
==Reference==
-
Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity., Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, Rollins CT, Stevenson LF, Magari SR, Wood SA, Courage NL, Lu X, Cerasoli F Jr, Gilman M, Holt DA, Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10437-42. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=9724721 9724721]
+
Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity., Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, Rollins CT, Stevenson LF, Magari SR, Wood SA, Courage NL, Lu X, Cerasoli F Jr, Gilman M, Holt DA, Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10437-42. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9724721 9724721]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Peptidylprolyl isomerase]]
[[Category: Peptidylprolyl isomerase]]
Line 32: Line 41:
[[Category: rotamase]]
[[Category: rotamase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:56:29 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 10:12:29 2008''

Revision as of 08:12, 20 March 2008


PDB ID 1bl4

Drag the structure with the mouse to rotate
, resolution 1.9Å
Ligands:
Activity: Peptidylprolyl isomerase, with EC number 5.2.1.8
Coordinates: save as pdb, mmCIF, xml



FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND


Overview

FKBP ligand homodimers can be used to activate signaling events inside cells and animals that have been engineered to express fusions between appropriate signaling domains and FKBP. However, use of these dimerizers in vivo is potentially limited by ligand binding to endogenous FKBP. We have designed ligands that bind specifically to a mutated FKBP over the wild-type protein by remodeling an FKBP-ligand interface to introduce a specificity binding pocket. A compound bearing an ethyl substituent in place of a carbonyl group exhibited sub-nanomolar affinity and 1,000-fold selectivity for a mutant FKBP with a compensating truncation of a phenylalanine residue. Structural and functional analysis of the new pocket showed that recognition is surprisingly relaxed, with the modified ligand only partially filling the engineered cavity. We incorporated the specificity pocket into a fusion protein containing FKBP and the intracellular domain of the Fas receptor. Cells expressing this modified chimeric protein potently underwent apoptosis in response to AP1903, a homodimer of the modified ligand, both in culture and when implanted into mice. Remodeled dimerizers such as AP1903 are ideal reagents for controlling the activities of cells that have been modified by gene therapy procedures, without interference from endogenous FKBP.

About this Structure

1BL4 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity., Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, Rollins CT, Stevenson LF, Magari SR, Wood SA, Courage NL, Lu X, Cerasoli F Jr, Gilman M, Holt DA, Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10437-42. PMID:9724721

Page seeded by OCA on Thu Mar 20 10:12:29 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools